SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-019786
Filing Date
2024-05-15
Accepted
2024-05-15 16:00:29
Documents
91
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1366219
2 ex31-1.htm EX-31.1 17825
3 ex31-2.htm EX-31.2 18442
4 ex32-1.htm EX-32.1 11820
  Complete submission text file 0001493152-24-019786.txt   8588275

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE invo-20240331.xsd EX-101.SCH 67641
6 XBRL CALCULATION FILE invo-20240331_cal.xml EX-101.CAL 70974
7 XBRL DEFINITION FILE invo-20240331_def.xml EX-101.DEF 372362
8 XBRL LABEL FILE invo-20240331_lab.xml EX-101.LAB 543129
9 XBRL PRESENTATION FILE invo-20240331_pre.xml EX-101.PRE 484394
94 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1204162
Mailing Address 5582 BROADCAST COURT SARASOTA FL 34240
Business Address 5582 BROADCAST COURT SARASOTA FL 34240 (978) 878-9505
INVO Bioscience, Inc. (Filer) CIK: 0001417926 (see all company filings)

IRS No.: 204036208 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39701 | Film No.: 24950067
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)